Skip to main content

Unable to load price data. Sorry.


YM BioSciences, Inc. (USA) (NYSEMKT:YMI.DL)

CAPS Rating: No stars

A biopharmaceutical company engaged in the development of products for the treatment of patients with cancer.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NYSEMKT:YMI.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

gildea1 (< 20)
Submitted January 20, 2012

Clinical results are also promising in the lower incidence of anemia with the YMI compound. Good results are often anticipated by the market. Here the reward opportunity is far greater than the risk--if only due to the low price of the stock. Being… More

zzlangerhans (98.80)
Submitted December 18, 2010

For those who missed the hint in my last red thumb, I was predicting the hefty dilutive financing that swatted down the share price a couple of weeks ago. Now the share price is back over 1.9 just days after the company sold 40M in stock at 1.6.… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about YMI.DL.

No one has written a Pitch for YMI.DL stock yet. Tell us why you think YMI.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in YMI.DL.

No players have picked YMI.DL yet. Tell us why you think YMI.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for YMI.DL.